{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:43:12Z","timestamp":1790718192506,"version":"4.1.0"},"reference-count":50,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,9,12]]},"abstract":"<jats:p>Background: Accumulating evidence suggests that adult vaccinations can reduce the risk of developing Alzheimer\u2019s disease (AD) and Alzheimer\u2019s disease related dementias. Objective: To compare the risk for developing AD between adults with and without prior vaccination against tetanus and diphtheria, with or without pertussis (Tdap\/Td); herpes zoster (HZ); or pneumococcus. Methods: A retrospective cohort study was performed using Optum\u2019s de-identified Clinformatics\u00ae Data Mart Database. Included patients were free of dementia during a 2-year look-back period and were\u226565 years old by the start of the 8-year follow-up period. We compared two similar cohorts identified using propensity score matching (PSM), one vaccinated and another unvaccinated, with Tdap\/Td, HZ, or pneumococcal vaccines. We calculated the relative risk (RR) and absolute risk reduction (ARR) for developing AD. Results: For the Tdap\/Td vaccine, 7.2% (n\u200a=\u200a8,370) of vaccinated patients and 10.2% (n\u200a=\u200a11,857) of unvaccinated patients developed AD during follow-up; the RR was 0.70 (95% CI, 0.68\u20130.72) and ARR was 0.03 (95% CI, 0.02\u20130.03). For the HZ vaccine, 8.1% (n\u200a=\u200a16,106) of vaccinated patients and 10.7% (n\u200a=\u200a21,417) of unvaccinated patients developed AD during follow-up; the RR was 0.75 (95% CI, 0.73\u20130.76) and ARR was 0.02 (95% CI, 0.02\u20130.02). For the pneumococcal vaccine, 7.92% (n\u200a=\u200a20,583) of vaccinated patients and 10.9% (n\u200a=\u200a28,558) of unvaccinated patients developed AD during follow-up; the RR was 0.73 (95% CI, 0.71\u20130.74) and ARR was 0.02 (95% CI, 0.02\u20130.03). Conclusion: Several vaccinations, including Tdap\/Td, HZ, and pneumococcal, are associated with a reduced risk for developing AD.<\/jats:p>","DOI":"10.3233\/jad-221231","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T11:36:11Z","timestamp":1691494571000},"page":"703-718","source":"Crossref","is-referenced-by-count":61,"title":["The Impact of Routine Vaccinations on Alzheimer\u2019s Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching"],"prefix":"10.1177","volume":"95","author":[{"given":"Kristofer","family":"Harris","sequence":"first","affiliation":[{"name":"Department of Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaobin","family":"Ling","sequence":"additional","affiliation":[{"name":"School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avram S.","family":"Bukhbinder","sequence":"additional","affiliation":[{"name":"Department of Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA"},{"name":"Division of Pediatric Neurology, Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal N.","family":"Phelps","sequence":"additional","affiliation":[{"name":"Department of Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Cruz","sequence":"additional","affiliation":[{"name":"Department of Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejin","family":"Kim","sequence":"additional","affiliation":[{"name":"School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Jiang","sequence":"additional","affiliation":[{"name":"School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Schulz","sequence":"additional","affiliation":[{"name":"Department of Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-221231_ref1","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1007\/s12035-018-1388-y","article-title":"the possibility of an infectious etiology of Alzheimer disease","volume":"56","author":"Ashraf","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-221231_ref2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3233\/JAD-140621","article-title":"Bacterial infection and Alzheimer\u2019s disease: A meta-analysis","volume":"43","author":"Maheshwari","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-221231_ref3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2174\/1570159X15666170313122937","article-title":"The infectious etiology of Alzheimer\u2019s disease","volume":"15","author":"Sochocka","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JAD-221231_ref4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1590\/1516-4446-2021-0037","article-title":"What is the role of microbial infection in Alzheimer\u2019s disease?","volume":"44","author":"Barichello","year":"2022","journal-title":"Braz J Psychiatry"},{"key":"10.3233\/JAD-221231_ref5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13073-023-01155-w","article-title":"The neuroimmune axis of Alzheimer\u2019s disease","volume":"15","author":"Jorfi","year":"2023","journal-title":"Genome Med"},{"key":"10.3233\/JAD-221231_ref6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12974-020-01741-4","article-title":"Influenza vaccination in early Alzheimer\u2019s disease rescues amyloidosis and ameliorates cognitive deficits in APP\/PS1 mice by inhibiting regulatory T cells","volume":"17","author":"Yang","year":"2020","journal-title":"J Neuroinflamm"},{"key":"10.3233\/JAD-221231_ref11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.imbio.2016.09.017","article-title":"The pertussis hypothesis: Bordetella pertussis colonization in the pathogenesis of Alzheimer\u2019s disease","volume":"222","author":"Rubin","year":"2016","journal-title":"Immunobiology"},{"key":"10.3233\/JAD-221231_ref13","unstructured":"Rabadi T , Brady MF (2022) Tetanus Toxoid, StatPearls Publishing, Treasure Island, FL."},{"key":"10.3233\/JAD-221231_ref14","first-page":"77","article-title":"Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: Updated recommendations of the Advisory Committee on Immunization Practices - United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"MMWR"},{"key":"10.3233\/JAD-221231_ref16","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: Towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"10.3233\/JAD-221231_ref17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40121-021-00567-8","article-title":"Meta-regression of herpes zoster incidence worldwide","volume":"11","author":"Curran","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.3233\/JAD-221231_ref18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4088\/JCP.16m11312","article-title":"Herpes zoster and dementia: A nationwide population-based cohort study","volume":"79","author":"Chen","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.3233\/JAD-221231_ref19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00406-020-01157-4","article-title":"Association of herpes zoster with dementia and effect of antiviral therapy on dementia: A population-based cohort study","volume":"271","author":"Bae","year":"2021","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.3233\/JAD-221231_ref20","doi-asserted-by":"crossref","first-page":"e0188490","DOI":"10.1371\/journal.pone.0188490","article-title":"Increased risk of dementia following herpes zoster ophthalmicus","volume":"12","author":"Tsai","year":"2017","journal-title":"PLoS One"},{"key":"10.3233\/JAD-221231_ref23","first-page":"1","article-title":"Prevention of herpes zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR"},{"key":"10.3233\/JAD-221231_ref24","first-page":"130","article-title":"Evaluation of efficacy and effectiveness of live attenuated zoster vaccine","volume":"55","author":"Gabutti","year":"2014","journal-title":"J Prev Med Hyg"},{"key":"10.3233\/JAD-221231_ref27","first-page":"109","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. Adults: Updated recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR"},{"key":"10.3233\/JAD-221231_ref28","first-page":"1069","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged\u226565 years: Updated recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Matanock","year":"2019","journal-title":"MMWR"},{"key":"10.3233\/JAD-221231_ref30","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/jgs.17606","article-title":"Comparison of rates of dementia among older adult recipients of two, one, or no vaccinations","volume":"70","author":"Wiemken","year":"2022","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-221231_ref31","doi-asserted-by":"crossref","first-page":"e0257405","DOI":"10.1371\/journal.pone.0257405","article-title":"Impact of herpes zoster vaccination on incident dementia: A retrospective study in two patient cohorts","volume":"16","author":"Scherrer","year":"2021","journal-title":"PLoS One"},{"key":"10.3233\/JAD-221231_ref32","doi-asserted-by":"crossref","first-page":"e045871","DOI":"10.1136\/bmjopen-2020-045871","article-title":"Shingles, Zostavax vaccination and risk of developing dementia: A nested case\u2013control study\u2014results from the UK Biobank cohort","volume":"11","author":"Lophatananon","year":"2021","journal-title":"BMJ Open"},{"key":"10.3233\/JAD-221231_ref33","doi-asserted-by":"crossref","first-page":"e12293","DOI":"10.1002\/trc2.12293","article-title":"Reduced dementia incidence after varicella zoster vaccination in Wales 2013-2020","volume":"8","author":"Schnier","year":"2022","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-221231_ref34","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/gerona\/glab115","article-title":"Lower risk for dementia following adult tetanus, diphtheria, and pertussis (Tdap) vaccination","volume":"76","author":"Scherrer","year":"2021","journal-title":"J Gerontol"},{"issue":"Suppl 3","key":"10.3233\/JAD-221231_ref35","doi-asserted-by":"crossref","first-page":"e046751","DOI":"10.1002\/alz.046751","article-title":"Repurposing of existing vaccines for personalized prevention of Alzheimer\u2019s disease: Vaccination against pneumonia may reduce AD risk depending on genotype: Genetics\/genetic factors of Alzheimer\u2019s disease","volume":"16","author":"Ukraintseva","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221231_ref36","doi-asserted-by":"crossref","first-page":"P1469","DOI":"10.1016\/j.jalz.2019.06.4108","article-title":"Vaccination against pneumonia in the elderly may reduce Alzheimer\u2019s risk","volume":"15","author":"Ukraintseva","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221231_ref37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1073\/pnas.1819612116","article-title":"On the mechanisms of conjugate vaccines","volume":"116","author":"Rappuoli","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-221231_ref38","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3233\/JAD-220361","article-title":"Risk of Alzheimer\u2019s disease following influenza vaccination: A claims-based cohort study using propensity score matching","volume":"88","author":"Bukhbinder","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-221231_ref39","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jalz.2018.02.016","article-title":"Identifying dementia cases with routinely collected health data: A systematic review","volume":"14","author":"Wilkinson","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221231_ref40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jalz.2016.04.002","article-title":"Prevalence of dementia subtypes in U.S. Medicare fee-for-service beneficiaries, 2011\u20132013","volume":"13","author":"Goodman","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221231_ref42","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1016\/j.vaccine.2021.08.046","article-title":"Dementia risk following influenza vaccination in a large veteran cohort","volume":"39","author":"Wiemken","year":"2021","journal-title":"Vaccine"},{"key":"10.3233\/JAD-221231_ref43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"10.3233\/JAD-221231_ref44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s10742-020-00222-8","article-title":"Veridical causal inference using propensity score methods for comparative effectiveness research with medical claims","volume":"21","author":"Ross","year":"2021","journal-title":"Health Serv Outcomes Res Method"},{"key":"10.3233\/JAD-221231_ref45","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/sim.3854","article-title":"The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies","volume":"29","author":"Austin","year":"2010","journal-title":"Stat Med"},{"key":"10.3233\/JAD-221231_ref46","doi-asserted-by":"crossref","unstructured":"Austin PC (2009) Type I error rates, coverage of confidence intervals, and variance estimation in propensity-score matched analyses. J Biostat 5, Article 13.","DOI":"10.2202\/1557-4679.1146"},{"key":"10.3233\/JAD-221231_ref47","unstructured":"Chen H , Harinen T , Jeong-Yoon L , Yung M , Zhao Z (2020) CausalML: Python Package for Causal Machine Learning. arXiv.org, https:\/\/doi.org\/10.48550\/arXiv.2002.11631"},{"key":"10.3233\/JAD-221231_ref48","doi-asserted-by":"crossref","first-page":"872542","DOI":"10.3389\/fimmu.2022.872542","article-title":"Adult vaccination as a protective factor for dementia: A meta-analysis and systematic review of population-based observational studies","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"10.3233\/JAD-221231_ref49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12979-017-0107-2","article-title":"Vaccines for the elderly: Current use and future challenges","volume":"15","author":"Weinberger","year":"2018","journal-title":"Immun Ageing"},{"key":"10.3233\/JAD-221231_ref50","first-page":"CD008858","article-title":"Vaccines for preventing herpes zoster in older adults","volume":"2019","author":"Gagliardi","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/JAD-221231_ref51","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/infdis\/jiy095","article-title":"Immune responses to a recombinant glycoprotein E herpes zoster vaccine in adults aged 50 years or older","volume":"217","author":"Cunningham","year":"2018","journal-title":"J Infect Dis"},{"key":"10.3233\/JAD-221231_ref52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3344\/kjp.2020.33.3.201","article-title":"Recombinant zoster vaccine (Shingrix (R)): A new option for the prevention of herpes zoster and postherpetic neuralgia","volume":"33","author":"Singh","year":"2020","journal-title":"Korean J Pain"},{"key":"10.3233\/JAD-221231_ref53","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1080\/21645515.2016.1261772","article-title":"Comparative evaluation of a newly developed 13-valent pneumococcal conjugate vaccine in a mouse model","volume":"13","author":"Park","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.3233\/JAD-221231_ref54","first-page":"1","article-title":"Surveillance of vaccination coverage among adult populations -United States, 2018","volume":"70","author":"Lu","year":"2021","journal-title":"MMWR"},{"key":"10.3233\/JAD-221231_ref55","first-page":"1","article-title":"Shingles vaccination among adults aged 60 and over: United States, 2018","author":"Terlizzi","year":"2020","journal-title":"NCHS Data Brief"},{"key":"10.3233\/JAD-221231_ref56","first-page":"245","article-title":"Decline in receipt of vaccines by medicare beneficiaries during the COVID-19 pandemic - United States, 2020","volume":"70","author":"Hong","year":"2021","journal-title":"MMWR"},{"key":"10.3233\/JAD-221231_ref57","doi-asserted-by":"crossref","first-page":"2027196","DOI":"10.1080\/21645515.2022.2027196","article-title":"Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States","volume":"18","author":"Curran","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.3233\/JAD-221231_ref58","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13584-016-0062-y","article-title":"Vaccine hesitancy: Understanding better to address better","volume":"5","author":"Kumar","year":"2016","journal-title":"Isr J Health Policy Res"},{"key":"10.3233\/JAD-221231_ref59","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ije\/dyp307","article-title":"Does BCG vaccination protect against the development of childhood asthma? A systematic review and meta-analysis of epidemiological studies","volume":"39","author":"El-Zein","year":"2010","journal-title":"Int J Epidemiol"},{"key":"10.3233\/JAD-221231_ref60","doi-asserted-by":"crossref","first-page":"7903","DOI":"10.1007\/s00253-019-10057-0","article-title":"Mycobacterium bovis BCG in metastatic melanoma therapy","volume":"103","author":"Benitez","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.3233\/JAD-221231_ref61","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.urolonc.2020.09.031","article-title":"Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer","volume":"39","author":"Sfakianos","year":"2021","journal-title":"Urol Oncol"},{"key":"10.3233\/JAD-221231_ref62","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1016\/j.vaccine.2021.04.062","article-title":"Older adults\u2019 vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake","volume":"39","author":"Nicholls","year":"2021","journal-title":"Vaccine"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-221231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:21Z","timestamp":1777370901000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-221231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":50,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-221231","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]}}}